Illumina and GenoScreen Partner to Expand Access to Genomic Testing for Multidrug-Resistant Tuberculosis ...Middle East

Transformative alliance will help advance the World Health Organization's strategy to end the global TB epidemic by 2035 SAN DIEGO, Oct. 18, 2022 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and GenoScreen, an innovative...

Hence then, the article about illumina and genoscreen partner to expand access to genomic testing for multidrug resistant tuberculosis was published today ( Tuesday 18/10/2022 - 01:20 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Illumina and GenoScreen Partner to Expand Access to Genomic Testing for Multidrug-Resistant Tuberculosis )

Also on site :

• The Strange GLP-1 Side Effect Plaguing Patients Months After Starting
• Man injured in Hove pub shooting
• Disney Fans Can Finally Experience Dole Whip in a Whole New Way